Bio Medica LaboratoriesNSE:BMLL +0.49%14 Interest Coverage is 10.82 as of Mar. 2025, which is 124% above its 10-year median of 4.82. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Bio Medica Laboratories ranks worse than 57.73% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bio Medica Laboratories's
Operating Income
for the
six
months ended in Mar. 2025 was ₹143.7 Mil. Bio Medica Laboratories's Interest Expense for the
six
months ended in Mar. 2025 was ₹-13.3 Mil.
Bio Medica Laboratories's interest coverage for the quarter that ended in Mar. 2025 was 10.82.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Bio Medica Laboratories's Interest Coverage or its related term are showing as below:
NSE:BMLL'
s Interest Coverage Range Over the Past 10 Years
Min: 1.65 Med: 4.82 Max: 10.82
Current: 10.82
NSE:BMLL's Interest Coverage is ranked worse than 57.73% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs NSE:BMLL: 10.82
Bio Medica Laboratories (NSE:BMLL) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bio Medica Laboratories Interest Coverage Related Terms
Bio Medica Laboratories Interest Coverage Historical Data
* Premium members only.
The historical data trend for Bio Medica Laboratories's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Bio Medica Laboratories Interest Coverage Chart
Bio Medica Laboratories Annual Data
Trend
Mar23
Mar24
Mar25
Interest Coverage
1.65
4.82
10.82
Bio Medica Laboratories Semi-Annual Data
Mar23
Mar24
Mar25
Interest Coverage
1.65
4.82
10.82
NSE:BMLL vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Medica Laboratories Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bio Medica Laboratories's Interest Coverage falls into.
Bio Medica Laboratories Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories (NSE:BMLL) has a Interest Coverage of 10.82 as of Mar. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bio Medica Laboratories and its competitors. This is 124% above median its historical median of 4.82. Over the past decade, Bio Medica Laboratories' Interest Coverage has ranged from 1.65 to 10.82. According to the industry distribution chart, Bio Medica Laboratories ranks #269 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 57.7%.
Is Bio Medica Laboratories' Interest Coverage too high?
Bio Medica Laboratories' current Interest Coverage of 10.82 is 124% above median its 10-year median of 4.82. Over the past 10 years, this metric has ranged from a low of 1.65 to a high of 10.82. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Bio Medica Laboratories' value of 10.82 is 31.8% below this industry median. Based on the distribution chart, Bio Medica Laboratories ranks #269 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #269 out of 466 companies for Interest Coverage. This places Bio Medica Laboratories in the lower half of its industry. The industry median Interest Coverage is 15.88. Bio Medica Laboratories' value of 10.82 is 31.8% below this benchmark. Historically, Bio Medica Laboratories' own Interest Coverage has ranged from 1.65 to 10.82 over the past decade. While the company's 10-year median is 4.82 vs. the industry median of 15.88, Bio Medica Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Medica Laboratories's current Interest Coverage of 10.82 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bio Medica Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current Interest Coverage is 10.82, which is 124% above median its own 10-year median of 4.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Interest Coverage of 10.82. The current Interest Coverage is 10.82, which is 124% above median its 10-year median of 4.82 and 31.8% below the Medical Devices & Instruments industry median of 15.88. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Interest Coverage is 10.82 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score
Get the complete analysis for NSE:BMLL
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BMLL has been successfully added to your 